Angiotensin II is a vasopressor peptide. It is filed in this library under heart & blood, a navigation topic rather than a statement of where it acts. As a regulatory matter it has at least one product approved by the FDA.
Regulatory status
Angiotensin II has an FDA-approved product on the U.S. market, marketed as Angiotensin Ii under application ANDA216966.
The current label is held by Gland Pharma Limited.
From the FDA label
ngiotensin II Injection increases blood pressure in adults with septic or other distributive shock.Quoted from the FDA-approved prescribing information
The evidence
2 sources on Angiotensin II published between 2001 and 2017, each resolved to its journal of record. Titles are listed so you can judge the evidence rather than take a summary on trust.
Nearby
A 60-second questionnaire, reviewed by a U.S.-licensed physician.
Find my protocolEducational reference only. This page explains what has been published about Angiotensin II. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.
Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
All 150 peptides